Stock PFIZER INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Pfizer Inc Nyse

Equities

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Pfizer Inc
Apr. 26 S&P 500 Posts First Weekly Gain Since March as Tech, Consumer Discretionary Lead Rise on Better-Than-Expected Earnings MT
Apr. 26 Sector Update: Health Care Stocks Edge Higher Late Afternoon MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
BU
Pfizer Declares Second-Quarter 2024 Dividend
BU
Pfizer : Political Action Committee (PAC) Report
PU
Second Circuit Rules That Associational Standing For A Preliminary Injunction Requires Identifying At Least One Injured Member By Name
AQ
Big pharma giants in English High Court for global Covid dispute
AQ
European Commission Approves Pfizer's EMBLAVEO for Patients with Multidrug-Resistant Infections and Limited Treatment Options
AQ
European Commission approves novel antibiotic
AQ
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
BU
Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M
AQ
University of Oregon: Options can lower vaccine hesitancy for COVID-19, other diseases
AQ
Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M
AQ
Pfizer : January 2023 – December 2023
PU
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
BU
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO in Adults Aged 18 to 59 at Increased Risk for RSV Disease
AQ
Pfizer : March Social Media Round-Up—Annual Review, International Women’s Day, and a School of Science Celebration
PU
Tempus Releases New Data at AACR Showcasing Ways to Analyze Multimodal Data to Highlight Potential Therapeutic Routes for HER2- Directed Antibody-Drug Conjugates in Several Tumor Types
AQ
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
BU
Working to “Outdo” Cancer: A Multi-Modality Approach to Accelerating the Next Generation of Cancer Breakthroughs
PU
The Kinetix Group and Pfizer Health Equity Work Recognized by PM360
AQ
Thinking about trading options or stock in NVIDIA, Trump Media & Technology, Microsoft, Enterprise Products Partners, or Pfizer?
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PFE Stock
  4. Stock
  5. News Pfizer Inc
  6. Press Releases